Synapse - Lanier R Tanner

Lanier R Tanner

Research Focus

Former Employee. Medicine; Clinical Research Supervisor

Recent additions – View all

Phase IB study of selinexor, a first-in-class inhibitor of nuclear export, in patients with advanced refractory bone or soft tissue sarcoma
Journal Article

Gounder, M. M.; Zer, A.; Tap, W. D.; Salah, S.; Dickson, M. A.; Gupta, A. A.; Keohan, M. L.; Loong, H. H.; D'Angelo, S. P.; Baker, S.; more...
Journal of Clinical Oncology (2016)

Fulltext@MSK | Save
A phase 1b study with selinexor, a first in class selective inhibitor of nuclear export (SINE) in patients with advanced sarcomas: An efficacy analysis
Meeting Abstract

Gounder, M. M.; Zer, A.; Tap, W. D.; Gupta, A. A.; Keohan, M. L.; Dickson, M. A.; D'Angelo, S. P.; Chi, P.; Tanner, L. R.; Konen, T.; more...
Journal of Clinical Oncology (2015)

Fulltext@MSK | Save
A phase 1b food effect study of the first-in-class, oral, selective inhibitor of nuclear export (SINE) selinexor (KPT-330) in patients (pts) with advanced sarcomas
Meeting Abstract

Gounder, M. M.; Loong, H. H. F.; Nyquist-Schultz, K.; Baker, S.; Ustoyev, Y.; Tanner, L. R.; Shacham, S.; McCauley, D.; Rashal, T.; Saint-Martin, J. R.; more...
Journal of Clinical Oncology (2014)

Fulltext@MSK | Save

Co-authors at MSK

4

Gounder
3

D'Angelo
3

Dickson
3

Keohan
3

Tap
2

Condy
2

Erinjeri
2

Schwartz
2

Ustoyev
1

Carvajal
1

Chi
1

Francis
1

Maki
1

Marshall
1

Morales
1

Qin
1

Wu

Types of Work

Publications

Journal of Clinical Oncology (4)